Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
Leucocyte migration inhibition in the presence of tumour crude ovarian tissue antigen was demonstrated in 64.51% of ovarian cancer patients, in 58.18% of other gynaecological carcinoma patients and in 19.04% of healthy individuals. Patients with benign ovarian disease showed 12.5% leucocyte migration inhibition. No significant difference was seen between results obtained in the presence of ovarian carcinoma antigen and normal ovary antigen.
D000941:Antigens; D000951:Antigens, Neoplasm; D002464:Cell Migration Inhibition; D002850:Chromatography, Gel; D003429:Cross Reactions; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000276:immunology*; D010053:Ovary / Q000276:immunology
D000941:Antigens; D000951:Antigens, Neoplasm